Percepta Nasal Swab

Search documents
Veracyte (VCYT) 2025 Conference Transcript
2025-06-04 19:00
Veracyte (VCYT) 2025 Conference June 04, 2025 02:00 PM ET Speaker0 Global Jefferies Healthcare Conference. My name is Camden Sisler with the Healthcare Investment Banking team. It's my great pleasure to introduce Rebecca Chambers, Chief Financial Officer of Veracyte. Speaker1 Thanks Camden. Thank you to Jeffries for having us. We're happy to be here. And thanks to you all for joining us today. I'm excited to walk you through Veracyte's recent progress, where we're headed next as we continue working to impro ...
Veracyte Stock Surges 30.9% in a Year: What's Driving the Rally?
ZACKS· 2025-05-19 13:40
Veracyte’s (VCYT) shares have surged 30.9% in the past year, showing impressive momentum. It has significantly outperformed the industry’s 13.1% decline and the S&P 500 composite’s 12.1% gain. Presently carrying a Zacks Rank #3 (Hold), the global diagnostics company continues to benefit from the robust performance of Afirma and Decipher tests. Their solid future growth potential, along with strategic investment in the long-term growth drivers, is highly promising.Based in San Francisco, CA, Veracyte offers ...
Veracyte Stock Gains on Q1 Earnings and Revenue Beat, Gross Margin Up
ZACKS· 2025-05-09 18:30
Veracyte, Inc. (VCYT) delivered first-quarter 2025 earnings of 31 cents per share, which marked a stupendous improvement of 63.2% from the year-ago period’s figure of 19 cents. The bottom line beat the Zacks Consensus Estimate by 55%.The company-adjusted earnings per share (EPS) were 9 cents compared to the year-ago period’s loss of 2 cents per share. Following the earnings announcement, VCYT’s share price gained 1.2% yesterday. VCYT’s Q1 RevenuesRevenues increased 18.3% year over year to $114.5 million, wh ...
Veracyte(VCYT) - 2025 Q1 - Earnings Call Transcript
2025-05-07 21:32
Veracyte (VCYT) Q1 2025 Earnings Call May 07, 2025 04:30 PM ET Company Participants Shayla Gorman - Senior Director - Investor RelationsMarc Stapley - CEORebecca Chambers - CFOSubbu Nambi - Managing DirectorJohn Leite - Global CCOPuneet Souda - Senior MDColleen Babington - Equity Research AssociateThomas DeBourcy - Principal Conference Call Participants Andrew Brackmann - Equity Research AnalystTejas Savant - Executive Director & Senior Healthcare Equity AnalystSung Ji Nam - Managing Director, Senior Equity ...
Veracyte(VCYT) - 2025 Q1 - Earnings Call Transcript
2025-05-07 21:30
Veracyte (VCYT) Q1 2025 Earnings Call May 07, 2025 04:30 PM ET Speaker0 and thank you for standing by. Welcome to the Veracyte First Quarter twenty twenty five Financial Results Webcast. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Sheila Gorman, Senior Director, Investor Relations. P ...